Table I.

Longitudinal Analysis of New Mammary Carcinomas

	Incidence of New Carcinomas
Latency:	0–12 months	13–24 months	>24 months	Mean Survival (months) (entire cohort)
SHAM No TAM	0 (n=30)	10.7% (3/28)	14% (2/14)	23.5 (n=30)
Sham + TAM	3.4% (1/29)	3.4% (1/28)	12% (3/25)	32.8 (n=29) p=.0001
300 cGy No TAM	25.9% (7/27)	50% (10/20)	33% (2/6)	21 (n=27)
300 cGy + TAM	0 (n=31)	23.3% (7/30)	33% (5/15)	24.3 (n=31) p=.0451
500 cGy No TAM	37.5% (12/32)	44% (8/18)	20% (1/5)	18.8 (n=32)
500 cGy + TAM	0 (n=29)	24.1% (7/29)	33% (5/15)	23.3 (n=29 p=.0066
900 cGy No TAM	20.8% (5/24)	38.9% (7/18)	0 (0/1)	18.9 (n=24)
900 cGy + TAM	0 (n=25)	23.8% (5/21)	25% (1/4)	20.2 (n=25) p=.3826
All Irrad No TAM	28.9% (24/83)	44.6% (25/56)	25% (3/12)	19.5 (n=83)
All Irrad TAM	0 (n=85)	23.5% (19/80)	32.4% (11/34)	22.8 (n=85) p=.0007